#SYNTHEMA enables research on diseases like leukaemia and sickle cell without exposing patient data, using AI-generated synthetic datasets.
Our models create realistic clinical, genetic, and imaging data, supporting safe and privacy-first research.
👉 synthema.eu
#AIInMedicine
If you're interested in regulation and ethics in AI for healthcare, don’t miss this session on MDR, the EU AI Act and privacy-preserving federated learning as part of the joint #SYNTHEMA and @erneurobloodnet.bsky.social training programme.
👉 Register: synthema.eu/training/
Missed it? The BDVA Healthcare Task Force white paper on synthetic data features #SYNTHEMA, led by Netcompany, alongside AISym4MED and SECURED. It shows how synthetic data can expand access, improve AI and enable more inclusive research.
Access the paper: synthema.eu/publications/
Join the first #SYNTHEMA webinar in our training series!
8 May 2026 | 12:30 CEST
Explore the @erneurobloodnet.bsky.social infrastructure for synthetic data: governance, strategy & architecture.
Open to patients & health professionals.
👉 synthema.eu/training/
Don’t miss it & share!
Good data is not just collected, it is built with care. In #SYNTHEMA, clinical teams across Europe are creating high-quality, privacy-compliant datasets to power synthetic data and AI research in rare blood disorders.
👉Read more: synthema.eu/2025/09/23/d...
At #SYNTHEMA we use AI to fill data gaps & improve care for rare blood disorders. Focusing on Sickle Cell Disease & Acute Myeloid Leukaemia, we integrate clinical, genetic & imaging data for improved patient outcomes.
👉 synthema.eu
#RareDiseases #Haematology
Interested in synthetic data and AI-powered breakthroughs in hematology? Visit SYNTHEMA’s publications section to explore the latest advancements by our team in data privacy, federated learning, AI for rare blood diseases, and more.
👉 Start reading: synthema.eu/publications/
#SYNTHEMA
Scientific progress depends on who gets to take part. In #SYNTHEMA, women contribute as researchers, clinicians and data specialists across all stages of the work. This day draws attention to how scientific careers are accessed: synthema.eu/2025/02/11/b...
It’s not enough for synthetic data to look real, it must be clinically useful. #SYNTHEMA tests if it can predict outcomes, reveal genetic risks & support real diagnoses.
Synthetic data means real impact.
👉 synthema.eu
#SyntheticData #AIHealthcare
#SYNTHEMA is part of the #HealthData4EU cluster, an alliance of EU-funded projects addressing fragmentation in health data across Europe through synthetic data generation, federated learning, and privacy-preserving technologies.
Laarn more: synthema.eu/healthdata4eu/
How can AI improve precision medicine in hematology?
The GEMINI Digital Twin platform, developed by the #SYNTHEMA & #GenoMed4Al consortia, integrates multimodal real-world data from 22,080 MDS patients to personalize clinical decision-making.
#MDS #Hematology #DigitalTwin
A short holiday break is approaching. Wishing partners, colleagues and everyone following #SYNTHEMA a peaceful holiday period, whatever it may look like for you.
Thank you for being part of a community committed to responsible research in rare hematological diseases.
synthema.eu
PW FedAvg, a new method by UPM researchers, improves treatment effect estimation in federated healthcare settings with imbalanced treatment distributions. It reduces causal inference errors where traditional FL methods fall short.
👉 synthema.eu/publications/
#SYNTHEMA #FederatedLearning
#SYNTHEMA joined the i~HD Annual Conference, with Elisabetta Mezzalira (University of Padova) representing the project. The event featured the presentation of the #HealthData4EU white paper “Building Trust in Synthetic Health Data”.
#SyntheticHealthData
Over 450 haematological diseases affect blood cells, the lymphatic system & coagulation, posing major challenges to public #HealthSystems.
#SYNTHEMA is developing a secure platform for synthetic #ClinicalData to enable GDPR-compliant research in rare #HaematologicalDiseases.
👉 synthema.eu
Can synthetic tabular data be more accurate?
This new model by researchers at Universidad Politécnica de Madrid combines a Variational Autoencoder with a Gaussian Mixture Model. Results outperform #CTGAN and #TVAE, especially on medical datasets.
👉 synthema.eu/publications/
#SYNTHEMA
The paper “Distributing trust: A P2P SMPC protocol for secure federated learning” by Petros Demetrakopoulos, Themistoklis Anagnostopoulos and Sofia Tsekeridou (Netcompany RID, #SYNTHEMA partner) will be presented at #FLLM2025 on 27 Nov at 15:30.
synthema.eu
How well does synthetic data generation work when spread across multiple hospitals? This study on #AML shows that federated learning protects privacy, though fidelity takes a hit. A key step in real-world AI for rare diseases.
👉 synthema.eu/publications
@vicomtech.bsky.social
#SYNTHEMA
Two productive days in San Sebastian for the #SYNTHEMA consortium have come to an end. Lively discussions, clear goals for the final year: a recap publication on synthetic data in haematology, joint training with @erneurobloodnet.bsky.social, new papers, and the SYNTHEMA platform launch
synthema.eu
By generating secure, high-quality synthetic data, #SYNTHEMA empowers researchers to push the frontiers of rare-disease research — safely, ethically, and collaboratively.
Learn more: synthema.eu
#AIinHealthcare #RareDiseases #SyntheticData #HorizonEurope
Pushing the boundaries of AI-based research in rare haematological diseases.
#SYNTHEMA develops privacy-preserving AI and synthetic data to create virtual patients that improve diagnosis and treatment in rare diseases.
👉 synthema.eu
#AIinHealthcare #HorizonEurope
Most synthetic data models assume data abundance. This study shows how transfer learning and meta-learning improve synthetic data generation for cancer research in low-data scenarios, where real clinical constraints apply.
👉 synthema.eu/publications/
#SYNTHEMA #SyntheticData #AI
Most synthetic data models assume data abundance. This study shows how transfer learning and meta-learning improve synthetic data generation for cancer research in low-data scenarios, where real clinical constraints apply.
👉 synthema.eu/publications/
#SYNTHEMA #CancerResearch
In #SYNTHEMA, data collection is central to building GDPR-compliant, AI-ready datasets for Sickle Cell Disease and Acute Myeloid Leukaemia. Harmonised across countries, the data supports synthetic generation, federated learning, and future rare disease research.
👉 synthema.eu/2025/09/23/d...
Data scarcity and fragmentation limit synthetic data in healthcare. This study introduces Synthetic Data Sharing, a federated learning method that improves representativeness and reduces disparities between data-rich and data-poor institutions.
👉 synthema.eu/publications/
#SYNTHEMA
Good data is not just collected, it is built with care. In #SYNTHEMA, clinical teams across Europe are creating high-quality, privacy-compliant datasets to power synthetic data and AI research in rare blood disorders.
👉Read more: synthema.eu/2025/09/23/d...
📰 The #BDVA Healthcare Task Force has published its white paper on Synthetic Data in Healthcare.
Proud to contribute alongside AISym4Med & SECURED, our sister projects in the #HEALTHDATA4EU cluster.
Read more 👉 bdva.eu/news/synthet...
#SyntheticData #SYNTHEMA
#SYNTHEMA is featured in The Innovation Platform (Issue 23), with an article on how synthetic data and federated AI are transforming research in rare blood disorders while keeping patient privacy at the core: www.innovationnewsnetwork.com/publication/...
#SyntheticData #RareDiseases
The #SYNTHEMA platform enables synthetic health data without moving sensitive patient info.
✔️ Data stays local
✔️ Federated learning across centres
✔️ FAIR-based quality & compliance
Tested in #SCD & #AML use cases. More info: synthema.eu
#SYNTHEMA is building the foundations for a future where synthetic, privacy-preserving data supports progress in rare diseases.
Beyond its two use cases, its flexible design can benefit other rare and underrepresented conditions.
More 👉 synthema.eu
